References
- 1Leyden E. Asthma and diabetes mellitus. Zeutschr Klin Med. 1881; 3:
358e64 . - 2Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974; 34(1): 29–34. DOI: 10.1016/0002-9149(74)90089-7
- 3Thrainsdottir IS, Aspelund T, Thorgeirsson G, et al. The association between glucose abnormalities and heart failure in the population-based Reykjavik study. Diabetes Care. 2005; 28(3): 612–6. DOI: 10.2337/diacare.28.3.612
- 4MacDonald MR, Petrie MC, Hawkins NM, et al. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J. 2008; 29(10): 1224–40. DOI: 10.1093/eurheartj/ehn156
- 5Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006; 27(22): 2725–36. DOI: 10.1093/eurheartj/ehl193
- 6Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149(2): 209–16. DOI: 10.1016/j.ahj.2004.08.005
- 7Amato L, Paolisso G, Cacciatore F, et al. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab. 1997; 23(3): 213–8.
- 8Andersson C, Norgaard ML, Hansen PR, et al. Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study. Eur J Heart Fail. 2010; 12(12): 1333–8. DOI: 10.1093/eurjhf/hfq160
- 9Guglin M, Lynch K, Krischer J. Heart Failure as a Risk Factor for Diabetes Mellitus. Cardiology. 2014; 129(2): 84–92. DOI: 10.1159/000363282
- 10Aroor AR, Mandavia CH, Sowers JR. Insulin Resistance and Heart Failure: Molecular Mechanisms. Heart Fail Clin. 2012; 8(4): 609–17. DOI: 10.1016/j.hfc.2012.06.005
- 11Paolisso G, De Riu S, Marrazzo G, Verza M, Varricchio M, D’Onofrio F. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism. 1991; 40(9): 972–7. DOI: 10.1016/0026-0495(91)90075-8
- 12Nichols GA, Moler EJ. Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes. Diabetologia. 2011; 54(3): 523–6. DOI: 10.1007/s00125-010-1965-8
- 13Shen L, Ramires F, Martinez F, et al. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy. Circ Heart Fail. 2017; 10(11). DOI: 10.1161/CIRCHEARTFAILURE.117.004361
- 14Echeverria LE, Morillo CA. American Trypanosomiasis (Chagas Disease). Infect Dis Clin. 1 Mar 2019; 33(1): 119–34. DOI: 10.1016/j.idc.2018.10.015
- 15Nunes MCP, Beaton A, Acquatella H, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation [Internet]. 18 Sep 2018; 138(12). DOI: 10.1161/CIR.0000000000000599 (assessed 12 Mar 2019).
- 16Ribeiro AL, Nunes MP, Teixeira MM, Rocha, MOC. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol. 2012; 9(10): 576–89. DOI: 10.1038/nrcardio.2012.109
- 17Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6): 1487–95. DOI: 10.2337/diacare.27.6.1487
- 18Parker ED, Pereira MA, Stevens J, Folsom AR. Association of Hip Circumference With Incident Diabetes and Coronary Heart Disease. Am J Epidemiol. 2009; 169(7): 837–47. DOI: 10.1093/aje/kwn395
- 19Conway B, Xiang Y-B, Villegas R, et al. Hip Circumference and the Risk of Type 2 Diabetes in Middle-aged and Elderly Men and Women: the Shanghai Women and Shanghai Men’s Health Studies. Ann Epidemiol. 2011; 21(5): 358–66. DOI: 10.1016/j.annepidem.2011.02.005
- 20Liu L, Pang Z, Wang S, et al. [Synergistic effect of diabetes family history and abnormal waist-to-hip ratio on the incidence of type 2 diabetes]. Wei Sheng Yan Jiu. 2012; 41(2): 308–10.
- 21Castagno D, Baird-Gunning J, Jhund PS, et al. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis. Am Heart J. 2011; 162(5): 938–948.e2. DOI: 10.1016/j.ahj.2011.07.030
- 22ALZadjali MA, Godfrey V, Khan F, et al. Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure. J Am Coll Cardiol. 2009; 53(9): 747–53. DOI: 10.1016/j.jacc.2008.08.081
- 23Guglin M, Villafranca A, Morrison A. Cardiogenic diabetes. Heart Fail Rev. 2014; 19(5): 595–602. DOI: 10.1007/s10741-013-9412-9
- 24Guglin M, Maguire K, Missimer T, Faber C, Caldeira C. Improvement in blood glucose control in patients with diabetes after implantation of left ventricular assist devices. ASAIO J Am Soc Artif Intern Organs. 1992. 2014; 60(3): 290–3. DOI: 10.1097/MAT.0000000000000064
- 25Koerner MM, El-Banayosy A, Eleuteri K, et al. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device. Heart Surg Forum. 2014; 17(2): E98–102. DOI: 10.1532/HSF98.2013323
- 26Subauste AR, Esfandiari NH, Qu Y, et al. Impact of left ventricular assist device on diabetes management: an evaluation through case analysis and clinical impact. Hosp Pract 1995. 2014; 42(3): 116–22. DOI: 10.3810/hp.2014.08.1124
- 27Uriel N, Naka Y, Colombo PC, et al. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices. Eur J Heart Fail. 2011; 13(2): 195–9. DOI: 10.1093/eurjhf/hfq204
- 28Yusuf S, Ostergren JB, Gerstein HC, et al. Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation. 2005; 112(1): 48–53. DOI: 10.1161/CIRCULATIONAHA.104.528166
- 29Vermes E, Ducharme A, Bourassa MG, et al. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation. 2003; 107(9): 1291–6. DOI: 10.1161/01.CIR.0000054611.89228.92
- 30Tanowitz HB, Jelicks LA, Machado FS, et al. Adipose Tissue, Diabetes and Chagas Disease. Adv Parasitol. 2011; 76: 235–50. DOI: 10.1016/B978-0-12-385895-5.00010-4
- 31Cabalén ME, Cabral MF, Sanmarco LM, et al. Chronic Trypanosoma cruzi infection potentiates adipose tissue macrophage polarization toward an anti-inflammatory M2 phenotype and contributes to diabetes progression in a diet-induced obesity model. Oncotarget. 2016; 7(12): 13400–15. DOI: 10.18632/oncotarget.7630
- 32Barbosa-Ferreira JM, Mady C, Ianni BM, et al. Dysregulation of Autonomic Nervous System in Chagas’ Heart Disease Is Associated with Altered Adipocytokines Levels. PLoS ONE [Internet]. 6 Jul 2015; 10(7). DOI:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493107/ (assessed 1 Apr 2019). DOI: 10.1371/journal.pone.0131447 - 33Dabarian AL, Mady C, Barbosa-Ferreira JM, et al. Dysregulation of insulin levels in Chagas heart disease is associated with altered adipocytokine levels. Can J Physiol Pharmacol. 2019; 97(2): 140–5. DOI: 10.1139/cjpp-2018-0349
- 34Dufurrena Q, Amjad FM, Scherer PE, et al. Alterations in pancreatic β cell function and Trypanosoma cruzi infection: evidence from human and animal studies. Parasitol Res. 2017; 116(3): 827–38. DOI: 10.1007/s00436-016-5350-5
- 35dos Santos VM, da Cunha SF, Teixeira Vde P, et al. Frequency of diabetes mellitus and hyperglycemia in chagasic and non-chagasic women. Rev Soc Bras Med Trop. 1999; 32(5): 489–96.